Given that diminished H3K4me3 levels are associated with reduced expression of EFNA1, we suggest that MAGEA12 acts through an, as of yet, unknown mechanism to activate chromatin and thereby regulate the transcription of genes involved in breast cancer cell malignancy. The gene discussed is EFNA1; the disease is breast cancer.